News from the FDA/CDC
Solriamfetol is the first dopamine and norepinephrine reuptake inhibitor approved to treat narcolepsy and obstructive sleep apnea.
Asking college students questions about their academic challenges, social lives, self-care, and sleep on campus will help you get them back on...
Children with ASD are more likely to have anxiety, which may predispose them to sleep problems.
SAN DIEGO – Identifying patients at risk for noncompliance and treating comorbid symptoms could improve compliance to CPAP therapy.
CORONADO, CALIF. – OSA prevalence in children with Down syndrome is estimated to be between 30% and 70%.
CORONADO, CALIF. – The findings could pave the way for studies of asthma pharmacotherapy as a way to treat OSA in...
Nearly half of Americans now have high blood pressure, in part due to the 2017 redefinition of hypertension.
The presence of laryngomalacia did not affect the rate of OSA resolution in this cohort of patients.
CORONADO, CALIF. – Finding underscores the overlap in symptoms between chronic rhinosinusitis and OSA.
Patients with the flu sent to the ICU had a more frequent history of sleep apnea, MI, and a BMI greater than 30 g/m2.